Pilot study to improve health outcomes for medication-induced headache sufferers

Canadian Journal of Clinical Pharmacology

Volumn 6, Issue 2, 1999, Pages 113-117

  Turner, Christopher J ^a,b   Pryse Phillips, William ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Health care team; Health outcomes; Medication induced headache; Rebound headache

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; BROMAZEPAM; BUTALBITAL; CAFFEINE; CODEINE; DIMENHYDRINATE; FLUNARIZINE; IBUPROFEN; PARACETAMOL; PETHIDINE; PHENOBARBITAL; PIZOTIFEN; PROPRANOLOL; SUMATRIPTAN;

ARTICLE; CANADA; DRUG USE; HEADACHE; HEALTH CARE; HUMAN; PATIENT INFORMATION; PHARMACIST; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0032789276     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982;33:335-41.
2. Rapoport AM. Analgesic rebound headache. Headache 1988;28:662-5.
3. Mathew NT. Drug-induced headache. Neurol Clin North Am 1990;8:903-12.
4. Silberstein SD, Young WB. Analgesic rebound headache: how great is the problem and what can be done? Drug Saf 1995;13:133-44.
5. Silberstein SD, Lipton RB. Chronic daily headache. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997:201-25.
6. Fisher CM. Analgesic rebound headache refuted. Headache 1988;28:666.
7. Baumgartner C, Wessely P, Bingol C, Maly T, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510-4.
8. MacGregor EA, Vohrah C, Wilkinson M. Analgesic use: A study of treatments used by patients for migraine prior to attending the City of London Migraine Clinic. Headache 1990;30:571-4.
9. Edmeads J. Analgesic-induced headaches: an unrecognized epidemic. Headache 1990;30:614-5.
10. Furlong S, Pryse-Phillips W, Crawley M, Turner CJ. Prescribing practices for the management of headache in Newfoundland and Labrador. Headache 1996;36:542-6.
11. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993;20:131-7.
12. Medication-induced headache: strategies for pharmacist identification and management. Halifax: BMC Health Associates Ltd, 1994.
13. Medication-Induced Headache: What is It? What Can You Do about It? Mississauga: Glaxo Canada Inc, 1994.
14. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-35.
15. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford hospital headache disability inventory (HDI). Neurology 1994;44:837-42.
16. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987;27:102-6.
17. Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992;19:333-9.
18. Headache classification committee of the international headache society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96.